Healthcare

Intuitive Surgical (ISRG +0.09%) and Vertex Pharmaceuticals (VRTX 0.79%) have posted excellent returns over the past 10 years,…

Enough time had passed since the patient’s previous colonoscopy that she met the criteria to undergo another, said…

dehaze, a Munich-based healthtech AI company, has raised €3.2 million in a seed funding round led by YZR…

Argentina’s vital statistics [PDF] offer several troubling signals for global health observers. After roughly two decades of steady…

A large-scale national study analyzing millions of U.S. births has uncovered a potential link between prenatal exposure to…

Weight loss is often associated with strict diets, detox routines or intense workout regimens. However, the real-world transformations…

“There’s more to testosterone than sex,” says David Edwards, a GP and former chair of the Primary Care…

Ajax’s lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with…

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But…

ASX healthcare stocks kept climbing the clinical milestone ladder during the March quarter. Pic: Getty Images Entropy advances…

Survivors have a heightened risk of developing cardiovascular disease, pain, insomnia, psychosocial distress and new cancers. Many, patient…

Sana and Mayo Clinic partner to advance a potential one-time cell therapy that could replace insulin for people…

Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?